GlassScriptPhysician profile
Benjamin J Barenberg
NPI 1124255922
$32,883.74
in general payments reported to CMS, 2019-2025
61 companies · $983 in 2025
The $983 reported for 2025 was more than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,821 · 2020: $1,072 · 2021: $17K · 2022: $6,791 · 2023: $649 · 2024: $678 · 2025: $983.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,140 · Education: $170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,140.08 |
| Education | $170.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $20,828.04 | 2019-2025 | Liletta |
| Amag Pharmaceuticals, INC. | $4,859.76 | 2019-2020 | |
| Ascend Therapeutics US, LLC | $1,194.89 | 2022 | |
| Medtronic USA, INC. | $756.75 | 2019-2020 | |
| Astellas Pharma US INC | $715.82 | 2019-2025 | Veozah, Myrbetriq |
| Gynesonics, INC. | $418.73 | 2021 | |
| Medtronic, INC. | $352.82 | 2021-2023 | Interstim |
| Minerva Surgical, INC | $288.02 | 2021-2025 | |
| Axonics, INC. | $252.75 | 2022-2024 | Axonics, Bulkamid |
| Therapeuticsmd, INC. | $220.64 | 2019-2021 | |
| Boston Scientific Corporation | $202.71 | 2024-2025 | Axonics, Advantage System, Bulkamid |
| Mayne Pharma Commercial LLC | $172.24 | 2021-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $161.20 | 2019-2023 | Xifaxan |
| Bayer Healthcare Pharmaceuticals INC. | $160.19 | 2019-2023 | |
| Amgen INC. | $158.51 | 2019-2021 |
Show all 61 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $149.47 | 2022 | |
| Daiichi Sankyo INC. | $141.44 | 2019-2022 | |
| Organon LLC | $127.74 | 2022-2025 | Nexplanon |
| Takeda Pharmaceuticals U.S.A., INC. | $124.65 | 2019-2022 | |
| Coloplast Corp | $121.83 | 2019-2022 | |
| Novo Nordisk INC | $121.72 | 2019-2023 | Rybelsus, Ozempic, Wegovy |
| Sumitomo Pharma America, INC. | $95.25 | 2023-2025 | Myfembree |
| Intuitive Surgical, INC. | $87.44 | 2020 | |
| Allergan, INC. | $73.99 | 2019-2021 | |
| Ibsa Pharma INC. | $73.04 | 2020-2025 | Tirosint, Licart, Flector |
| Amneal Pharmaceuticals LLC | $65.05 | 2025 | Unithroid |
| Myovant Sciences INC. | $64.70 | 2021-2022 | |
| Virtus Pharmaceuticals LLC | $60.96 | 2021 | |
| Lilly USA, LLC | $55.81 | 2021-2024 | Jardiance, Zepbound |
| Hologic Sales and Service, LLC | $53.76 | 2019-2024 | Aptima, Thinprep 2000 Processor |
| Avion Pharmaceuticals | $52.97 | 2021 | |
| Millicent US INC | $48.77 | 2023-2025 | Intrarosa, Femring, Femlyv |
| Pfizer INC. | $42.81 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $41.46 | 2019-2022 | |
| Meditrina | $39.36 | 2022-2024 | |
| Eisai INC. | $32.46 | 2019-2020 | |
| Mission Pharmacal Company | $32.14 | 2020 | |
| Exeltis, USA INC. | $31.30 | 2023-2024 | Slynd |
| Vertical Pharmaceuticals, LLC | $29.28 | 2019-2020 | |
| Mylan Pharmaceuticals INC. | $28.22 | 2021 | |
| Pharmacosmos Therapeutics INC. | $23.69 | 2021 | |
| Ethicon US, LLC | $21.34 | 2022 | |
| Lundbeck LLC | $21.21 | 2022 | |
| Vivus LLC | $20.72 | 2019 | |
| Curonix LLC | $19.71 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Vertex Pharmaceuticals Incorporated | $19.43 | 2025 | |
| Valencia Technologies Corporation | $18.53 | 2025 | Ecoin Device Kit |
| Roche Diagnostics Corporation | $18.39 | 2019 | |
| Bausch Health US, LLC | $17.29 | 2019 | |
| Radius Health, INC. | $16.88 | 2020 | |
| Scynexis, INC. | $15.78 | 2022 | |
| Dexcom, INC. | $15.46 | 2024 | Dexcom G6 Transmitter |
| Acella Pharmaceuticals, LLC | $14.64 | 2025 | NP Thyroid 60 |
| Corcept Therapeutics | $14.56 | 2024 | Korlym |
| Endo Pharmaceuticals INC. | $14.55 | 2020 | |
| Shire North American Group INC | $14.45 | 2019 | |
| Ardelyx, INC. | $14.36 | 2023 | Ibsrela |
| Horizon Therapeutics Plc | $13.98 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $13.45 | 2022 | |
| Nestle Healthcare Nutrition INC. | $11.11 | 2021 | |
| Channel Medsystems, INC. | $5.52 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Barenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.